230 related articles for article (PubMed ID: 10737675)
1. PYY preference is a common characteristic of neuropeptide Y receptors expressed in human, rat, and mouse gastrointestinal epithelia.
Holliday ND; Pollock EL; Tough IR; Cox HM
Can J Physiol Pharmacol; 2000 Feb; 78(2):126-33. PubMed ID: 10737675
[TBL] [Abstract][Full Text] [Related]
2. The functional investigation of a human adenocarcinoma cell line, stably transfected with the neuropeptide Y Y1 receptor.
Holliday ND; Cox HM
Br J Pharmacol; 1996 Sep; 119(2):321-9. PubMed ID: 8886416
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y, Y1, Y2 and Y4 receptors mediate Y agonist responses in isolated human colon mucosa.
Cox HM; Tough IR
Br J Pharmacol; 2002 Mar; 135(6):1505-12. PubMed ID: 11906964
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
Haynes JM; Hill SJ; Selbie LA
Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
6. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
[TBL] [Abstract][Full Text] [Related]
7. Y(4) receptors mediate the inhibitory responses of pancreatic polypeptide in human and mouse colon mucosa.
Tough IR; Holliday ND; Cox HM
J Pharmacol Exp Ther; 2006 Oct; 319(1):20-30. PubMed ID: 16807358
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
Gehlert DR; Schober DA; Morin M; Berglund MM
Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631
[TBL] [Abstract][Full Text] [Related]
10. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
Iyengar S; Li DL; Simmons RM
J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of neuropeptide Y Y1 receptors by BIBP3226 in rat and human epithelial preparations.
Tough IR; Cox HM
Eur J Pharmacol; 1996 Aug; 310(1):55-60. PubMed ID: 8880067
[TBL] [Abstract][Full Text] [Related]
12. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.
Chu DQ; Cox HM; Costa SK; Herzog H; Brain SD
Br J Pharmacol; 2003 Sep; 140(2):422-30. PubMed ID: 12970079
[TBL] [Abstract][Full Text] [Related]
13. Characterization of G protein and phospholipase C-coupled agonist binding to the Y1 neuropeptide Y receptor in rat brain: sensitivity to G protein activators and inhibitors and to inhibitors of phospholipase C.
Parker SL; Parker MS; Sweatman T; Crowley WR
J Pharmacol Exp Ther; 1998 Jul; 286(1):382-91. PubMed ID: 9655883
[TBL] [Abstract][Full Text] [Related]
14. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
Goumain M; Voisin T; Lorinet AM; Laburthe M
Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y receptors; antisecretory control of intestinal epithelial function.
Cox HM
Auton Neurosci; 2007 Apr; 133(1):76-85. PubMed ID: 17140858
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y stimulates bile secretion via Y1 receptor in the left dorsal vagal complex in rats.
Yoneda M; Nakamura K; Yokohama S; Tamori K; Sato Y; Aso K; Aoshima M; Kono T; Makino I
Hepatology; 1998 Sep; 28(3):670-6. PubMed ID: 9731557
[TBL] [Abstract][Full Text] [Related]
17. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).
Dumont Y; Cadieux A; Doods H; Fournier A; Quirion R
Can J Physiol Pharmacol; 2000 Feb; 78(2):116-25. PubMed ID: 10737674
[TBL] [Abstract][Full Text] [Related]
18. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.
Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B
Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of receptors with affinity for PYY, NPY, [Leu31,Pro34]NPY and PP in a human colonic epithelial cell line.
Cox HM; Tough IR
Br J Pharmacol; 1995 Nov; 116(6):2673-8. PubMed ID: 8590988
[TBL] [Abstract][Full Text] [Related]
20. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
